跳至主要内容
临床试验/NCT05631587
NCT05631587已完成不适用

A Technology-based Intervention for Promoting Physical Activity Among Post-treatment Cancer Survivors

The University of Hong Kong1 个研究点 分布在 1 个国家目标入组 98 人开始时间: 2022年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
98
试验地点
1
主要终点
Change in aerobic exercise behaviour (subjective measure)

研究概览

简要总结

Cancer survivors generally have low physical activity (PA) levels. While literature shows some evidence of improvement in PA following technology-based PA promotion interventions among cancer survivors, high-quality randomised control trials (RCTs), with objective measures of PA and longer-term follow-up, are lacking. Using a theoretical framework that addresses action control in addition to intention formation may enhance intervention effect. The Multi-process action control (M-PAC) framework is an extension of the traditional intention-formation theories, incorporating constructs that address the translation of intention into behaviour and continual action control. After comprehensively searching, no previous or ongoing RCTs have investigated the efficacy of a technology-based PA promotion intervention in cancer survivors that is designed based on the M-PAC framework. Investigators therefore propose a RCT to evaluate a technology-based intervention (WExercise) to support the promotion of PA in cancer survivors.

详细描述

Objective: To develop a technology-based physical activity promotion intervention (WExercise) for cancer survivors based on the Multi-process Action Control (M-PAC) Framework and examine its usability and efficacy.

Main hypothesis: The WExercise group will have a significantly greater increase in aerobic exercise than the self-directed exercise group at post-intervention.

Design: Phase 1- Application development; Phase 2- Usability testing (n=10); Phase 3- Assessor-blind two-arm randomized controlled trial (n=98; WExercise or self-directed exercise group).

Subjects: Physically inactive cancer survivors who have completed curative treatment.

Study instruments: Accelerometry, Godin Leisure Time Exercise Questionnaire, 6-minute walk test, EORTC QLQ-C30, M-PAC questionniare; administered at baseline, post-intervention, and 3 months post-intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18 years of age
  • completion of primary treatment (surgery/chemo-/radiation therapy) of curative intent for at least 12 months,
  • no metastasis, no recurrence
  • not meeting the recommended PA guideline (<150 min of moderate intensity aerobic exercise and <75 min of vigorous aerobic exercise per week)
  • access to Internet
  • able to read Chinese and communicate in Cantonese or Putonghua
  • screened by a nurse as no contraindications for engaging in unsupervised exercise using a risk screening tool

排除标准

  • have a psychiatric disorder
  • significant cognitive impairment
  • a history of more than one cancer

结局指标

主要结局

Change in aerobic exercise behaviour (subjective measure)

时间窗: Measure at Baseline (Week 0), Post-intervention (Week 11), 3 months post-intervention (Week 23). Self-reported minutes of moderate-to-vigorous aerobic exercise will be recorded.

Measured by the Godin Leisure Time Exercise Questionnaire (Min and Max NA; higher scores represent higher aerobic exercise level)

Change in aerobic exercise behaviour (objective measure)

时间窗: Measure at Baseline (Week 0), Post-intervention (Week 11), 3 months post-intervention (Week 23). Each time point will measure 7 full consecutive days and average time (minutes) per day spent in moderate-to-vigorous aerobic exercise will be reported.

Measured as time spent in moderate-to-vigorous aerobic exercise using accelerometer

次要结局

  • Change in exercise capacity(Measure at Baseline (Week 0), Post-intervention (Week 11), 3 months post-intervention (Week 23).)
  • Change in key components of M-PAC framework(Measure at Baseline (Week 0), Mid-intervention (Week 5), Post-intervention (Week 11), 3 months post-intervention (Week 23).)
  • Change in cancer-specific Quality of life(Measure at Baseline (Week 0), Post-intervention (Week 11), 3 months post-intervention (Week 23).)
  • Application usage(Measure at post-intervention (Week 11))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Cheung Shuk-Ting

Assistant Professor

The University of Hong Kong

研究点 (1)

Loading locations...

相似试验